Overview

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 compared to lactulose in patients with mild hepatic encephalopathy.
Phase:
Phase 2
Details
Lead Sponsor:
Ocera Therapeutics
Treatments:
Lactulose